section i place: agency for health care adm notice of ... · statement of estimated regulatory...

23
Florida Administrative Register Volume 44, Number 185, September 21, 2018 4349 Section I Notice of Development of Proposed Rules and Negotiated Rulemaking NONE Section II Proposed Rules AGENCY FOR HEALTH CARE ADMINISTRATION Cost Management and Control RULE NO.: RULE TITLE: 59B-12.001 Bone Marrow Transplantation PURPOSE AND EFFECT: The Agency is proposing to amend Rule 59B-12.001, F.A.C., to update procedures based on recommendations from the Bone Marrow Transplant Advisory Panel. SUMMARY: The proposed amendments include coverage for cellular therapies which include cellular immunotherapies, chimeric antigen receptor (CAR) T cells, cancer vaccines, and other types of autologous and allogeneic cells for certain therapeutic indications. The language mirrors that of the Food and Drug Administration’s language for approved cellular therapy. New language adds to the specific conditions for which the use of cellular therapies is necessary. The amendments also adjust the conditions in sections one through three to add or move conditions to the proper section. SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION: The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency. Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice. RULEMAKING AUTHORITY: 627.4236 F.S. LAW IMPLEMENTED: 627.4236 F.S. IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW (IF NOT REQUESTED, THIS HEARING WILL NOT BE HELD): DATE AND TIME: Tuesday, October 16, 2018, 9:00 a.m. PLACE: Agency for Health Care Administration, Building #3, Florida Center Conference Room, 2727 Mahan Dr., Tallahassee, FL 32308 Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 3 days before the workshop/meeting by contacting: Dana Watson, (850)412-3784, email:[email protected].. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice). THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Dana Watson, (850)412-3784, email:[email protected]. THE FULL TEXT OF THE PROPOSED RULE IS: 59B-12.001 Bone Marrow Transplantation Bone marrow transplant refers collectively to hematopoietic stem cell transplantation using stem cells that are collected from peripheral blood and cord blood as well as bone marrow following a conditioning regimen. As used in this rule, the term “appropriate oncological specialty” means that where a particular kind of tumor or disease is usually treated by a subspecialty group within the general discipline of oncology, those who practice within that subspecialty have had specific input into the decision making process. Cellular therapies therapy products include cellular immunotherapies, chimeric antigen receptor (CAR) T cells, cancer vaccines, and other types of both autologous and allogeneic cells for certain therapeutic indications. Human gene therapy refers to products that introduce genetic material into a person’s DNA to replace faulty or missing genetic material, thus treating a disease or abnormal medical condition. (1) Upon the recommendation of the Bone Marrow Transplant Panel, each of the following procedures meets a minimum level of evidence based on high quality systematic reviews of case control or cohort studies, high quality case- control or cohort studies with a very low risk of confounding bias, or chance, and a high probability that the relationship is causal, and is considered accepted within the appropriate oncological specialty and not experimental for the purposes of Section 627.4236, F.S. (a) Autologous bone marrow transplant for acute myelogenous leukemia (stem cells collected in remission); (b) Allogeneic bone marrow transplant for acute myelogenous leukemia and myeloid sarcoma; (c) Allogeneic bone marrow transplant for acute lymphoblastic leukemia;

Upload: phungque

Post on 08-Jun-2019

213 views

Category:

Documents


0 download

TRANSCRIPT

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4349

Section I

Notice of Development of Proposed Rules

and Negotiated Rulemaking

NONE

Section II

Proposed Rules

AGENCY FOR HEALTH CARE ADMINISTRATION

Cost Management and Control

RULE NO.: RULE TITLE:

59B-12.001 Bone Marrow Transplantation

PURPOSE AND EFFECT: The Agency is proposing to amend

Rule 59B-12.001, F.A.C., to update procedures based on

recommendations from the Bone Marrow Transplant Advisory

Panel.

SUMMARY: The proposed amendments include coverage for

cellular therapies which include cellular immunotherapies,

chimeric antigen receptor (CAR) T cells, cancer vaccines, and

other types of autologous and allogeneic cells for certain

therapeutic indications. The language mirrors that of the Food

and Drug Administration’s language for approved cellular

therapy.

New language adds to the specific conditions for which the use

of cellular therapies is necessary. The amendments also adjust

the conditions in sections one through three to add or move

conditions to the proper section.

SUMMARY OF STATEMENT OF ESTIMATED

REGULATORY COSTS AND LEGISLATIVE

RATIFICATION:

The Agency has determined that this will not have an adverse

impact on small business or likely increase directly or indirectly

regulatory costs in excess of $200,000 in the aggregate within

one year after the implementation of the rule. A SERC has not

been prepared by the Agency.

Any person who wishes to provide information regarding a

statement of estimated regulatory costs, or provide a proposal

for a lower cost regulatory alternative must do so in writing

within 21 days of this notice.

RULEMAKING AUTHORITY: 627.4236 F.S.

LAW IMPLEMENTED: 627.4236 F.S.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS

NOTICE, A HEARING WILL BE HELD AT THE DATE,

TIME AND PLACE SHOWN BELOW (IF NOT

REQUESTED, THIS HEARING WILL NOT BE HELD):

DATE AND TIME: Tuesday, October 16, 2018, 9:00 a.m.

PLACE: Agency for Health Care Administration, Building #3,

Florida Center Conference Room, 2727 Mahan Dr.,

Tallahassee, FL 32308

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 3 days before the workshop/meeting by

contacting: Dana Watson, (850)412-3784,

email:[email protected].. If you are hearing or

speech impaired, please contact the agency using the Florida

Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770

(Voice).

THE PERSON TO BE CONTACTED REGARDING THE

PROPOSED RULE IS: Dana Watson, (850)412-3784,

email:[email protected].

THE FULL TEXT OF THE PROPOSED RULE IS:

59B-12.001 Bone Marrow Transplantation

Bone marrow transplant refers collectively to hematopoietic

stem cell transplantation using stem cells that are collected from

peripheral blood and cord blood as well as bone marrow

following a conditioning regimen. As used in this rule, the term

“appropriate oncological specialty” means that where a

particular kind of tumor or disease is usually treated by a

subspecialty group within the general discipline of oncology,

those who practice within that subspecialty have had specific

input into the decision making process. Cellular therapies

therapy products include cellular immunotherapies, chimeric

antigen receptor (CAR) T cells, cancer vaccines, and other

types of both autologous and allogeneic cells for certain

therapeutic indications. Human gene therapy refers to products

that introduce genetic material into a person’s DNA to replace

faulty or missing genetic material, thus treating a disease or

abnormal medical condition.

(1) Upon the recommendation of the Bone Marrow

Transplant Panel, each of the following procedures meets a

minimum level of evidence based on high quality systematic

reviews of case control or cohort studies, high quality case-

control or cohort studies with a very low risk of confounding

bias, or chance, and a high probability that the relationship is

causal, and is considered accepted within the appropriate

oncological specialty and not experimental for the purposes of

Section 627.4236, F.S.

(a) Autologous bone marrow transplant for acute

myelogenous leukemia (stem cells collected in remission);

(b) Allogeneic bone marrow transplant for acute

myelogenous leukemia and myeloid sarcoma;

(c) Allogeneic bone marrow transplant for acute

lymphoblastic leukemia;

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4350

(d) Allogeneic bone marrow transplant for chronic

myelogenous leukemia;

(e) Autologous bone marrow transplant for Hodgkin

lymphoma;

(f) Allogeneic bone marrow transplant for Hodgkin

lymphoma after autologous stem cell collection failure or

relapsed after autologous transplant but not progressing on

salvage chemotherapy;

(g) Autologous bone marrow transplant for non-Hodgkin

lymphoma;

(h) Allogeneic bone marrow transplant for non-Hodgkin

lymphoma;

(i) Autologous bone marrow transplant for Ewing sarcoma,

chemotherapy sensitive after first relapse;

(j) Autologous bone marrow transplant for neuroblastoma;

(k) Autologous bone marrow transplant for germ cell

tumor, after failure of first therapy but not progressing on

salvage therapy;

(l) Autologous bone marrow transplant for multiple

myeloma (including double bone marrow transplant),

Waldenstrom macroglobulinemia and primary amyloidosis;

(m) Allogeneic bone marrow transplant for

myelodysplastic syndrome;

(n) Autologous bone marrow transplant for primitive

neuroectodermal tumor (PNET), (including medulloblastoma

and pinealoblastoma), chemotherapy sensitive after first

relapse;

(o) Autologous bone marrow for medulloblastoma and

other PNET tumors, metastatic, at diagnosis;

(p) Allogeneic bone marrow transplant for chronic

lymphocytic leukemia;

(q) Allogeneic bone marrow transplant for severe or very

severe aplastic anemia from HLA compatible siblings and any

type of bone marrow transplant for acquired or genetic severe

aplastic anemia unresponsive to immunosuppression;

(r) Allogeneic bone marrow transplant for sickle cell

anemia, thalassemia, and other severe red cell disorders; and,

(s) Allogeneic bone marrow transplant for severe

combined immune deficiency disorder and other severe

immune deficiency disorders.

(t) Tisagenlecleucel, a CD19-directed, genetically

modified autologous T cell immunotherapy is medically

necessary for patients up to 25 years of age with B-cell

precursor acute lymphoblastic leukemia that is refractory or in

second or later relapse.

(u) Axicabtagene ciloleucel, a CD19-directed, genetically

modified autologous T cell immunotherapy is medically

necessary for adult patients with relapsed or refractory large B-

cell lymphoma after two or more lines of systemic therapy,

including diffuse large B-cell lymphoma not otherwise

specified, primary mediastinal large B-cell lymphoma, high

grade B-cell lymphoma, and diffuse large B-cell lymphoma

arising from follicular lymphoma.

(v) Cellular therapies that are Food and Drug

Administration (FDA)-approved for a specific indication and

are medically necessary, accepted within the appropriate

oncological specialty and not experimental for the purposes of

Section 627.4236, F.S.

In cases where treatment for any of the above conditions

includes a clinical trial that conforms to subsection (6) routine

care costs associated with the bone marrow transplant will be

covered.

(2) Each of the following procedures is considered

accepted within the appropriate oncological specialty and not

experimental for the purposes of Section 627.4236, F.S.,

provided that the bone marrow transplantation procedure is

performed in the context of a well-designed clinical treatment

trial as described in subsection (6).

Routine care costs associated with the bone marrow

transplant will be covered for the following procedures:

(a) Autologous bone marrow transplant for chronic

lymphocytic leukemia;

(b) Autologous bone marrow transplant for plasma cell

dyscrasias other than multiple myeloma (e.g., Waldenstrom);

(b)(c) Allogeneic bone marrow transplant for multiple

myeloma and other plasma cell dyscrasias (e.g., Waldenstrom,

amyloid);

(c)(d) Autologous bone marrow transplant for breast

carcinoma;

(d)(e) Autologous bone marrow transplant for Ewing

sarcoma, localized, greater than eight cm or metastatic at

presentation;

(e)(f) Autologous bone marrow transplant for soft tissue

sarcoma, pediatric, after failure of first therapy;

(f)(g) Autologous bone marrow transplant for Wilms

tumor, at relapse;

(g)(h)Autologous bone marrow transplant for germ cell

tumor, high risk, at diagnosis;

(h)(i) Allogeneic bone marrow transplant for renal cell

carcinoma;

(i)(j)Multiple autologous bone marrow transplants for

pediatric solid tumors;

(k) Allogeneic bone marrow transplant for Hodgkin

lymphoma;

(j)(l)Autologous bone marrow transplant for metastatic

malignant melanoma;

(k)(m) Allogeneic bone marrow transplant for sickle cell

anemia, thalassemia, and other severe red cell disorders; and,

(l) Cellular therapies and human gene therapies that are

provided on clinical trial at a Blood and Marrow Transplant

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4351

Clinical Trials Network (BMT CTN) core or non-core center,

and are accepted within the appropriate oncological specialty

and not experimental for the purposes of Section 627.4236 F.S.

(m)(n) Autologous bone marrow transplant for

autoimmune disorders.

(3) The following rare diseases, where there are no existing

clinical trials available, are covered for bone marrow transplant

at the Blood and Marrow Transplant Clinical Trials Network

(BMT CTN) core or non-core facilities when deemed medically

necessary:

(a) Myelofibrosis;

(b) Chronic myelomonocytic leukemia (CMML);

(c) Paroxysmal nocturnal hemoglobinuria (PNH); and,

(d) POEMS syndrome.

(4) Transplants from living related donors incompatible for

one HLA-A, -B, and -DRB1 loci are covered for bone marrow

transplant at BMT CTN core or non-core medical facilities.

(5) Any bone marrow transplant performed outside of a

clinical trial will be covered when all the following criteria are

met:

(a) The plan of care follows a clinical trial protocol that

meets the requirements of subsection (5);

(b) Patient cannot be enrolled in the proposed clinical trial;

(c) Bone marrow transplant treatment is medically

necessary;

(d) Patient is an appropriate candidate for bone marrow

transplant; and,

(e) Treatment center is part of the BMT CTN at a core or

non-core center.

(6) A well-designed and conducted clinical treatment trial

is one which includes an IRB-approved written protocol. At a

minimum, such protocol shall have specific criteria for

evaluating the effect of treatment with defined endpoints that

are precise, meaningful, and reliable and which allow valid

conclusions to be drawn about therapeutic efficacy and safety.

Protocols should include an adequate statistical section

describing the method of randomization and stratification, if

any, expected outcome parameters relating to response rates,

time to progression, survival times and other relevant

information. Such clinical treatment trials shall be consistent

with protocols reviewed and approved by the National Cancer

Institute for scientific merit.

Rulemaking Authority 627.4236 FS. Law Implemented 627.4236 FS.

History–New 11-9-95, Formerly 10D-127.001, Amended 9-26-00, 8-

10-05, 7-7-13, 7-12-15, .

NAME OF PERSON ORIGINATING PROPOSED RULE:

Dana Watson, (850)412-3784, email:

[email protected].

NAME OF AGENCY HEAD WHO APPROVED THE

PROPOSED RULE: Secretary Justin Senior

DATE PROPOSED RULE APPROVED BY AGENCY

HEAD: August 23, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT

PUBLISHED IN FAR: 6/21/2018

DEPARTMENT OF HEALTH

Board of Medicine

RULE NOS.: RULE TITLES:

64B8-30.014 Citation Authority

64B8-30.015 Disciplinary Guidelines

PURPOSE AND EFFECT: The proposed rule amendments are

intended to set forth citation violations and disciplinary

guidelines for the failure of physician assistants to consult the

prescription drug monitoring system. Additionally, the Rule

64B8-30.015 is being amended to change penalties for

prescribing medicinal drugs or controlled substances which

demonstrates a lack of reasonable skill or safety to patients.

SUMMARY: The proposed rule amendments to 64B8-30.014

set forth a first, second and third-time penalty for physician

assistants who fail to consult the prescription drug monitoring

system. The amendments to Rule 64B8-30.015 set forth revised

penalties for prescribing medicinal drugs or controlled

substances which demonstrates a lack of reasonable skill or

safety to patients; and set forth a penalty for failure to consult

the prescription drug monitoring system.

SUMMARY OF STATEMENT OF ESTIMATED

REGULATORY COSTS AND LEGISLATIVE

RATIFICATION:

The Agency has determined that this will not have an adverse

impact on small business or likely increase directly or indirectly

regulatory costs in excess of $200,000 in the aggregate within

one year after the implementation of the rule. A SERC has not

been prepared by the Agency.

The Agency has determined that the proposed rule is not

expected to require legislative ratification based on the

statement of estimated regulatory costs or if no SERC is

required, the information expressly relied upon and described

herein: During discussion of the economic impact of this rule at

its Board meeting, the Board concluded that this rule change

will not have any impact on licensees and their businesses or

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4352

the businesses that employ them. The rule will not increase any

fees, business costs, personnel costs, will not decrease profit

opportunities, and will not require any specialized knowledge

to comply. This change will not increase any direct or indirect

regulatory costs. Hence, the Board determined that a Statement

of Estimated Regulatory Costs (SERC) was not necessary and

that the rule will not require ratification by the Legislature. No

person or interested party submitted additional information

regarding the economic impact at that time.

Any person who wishes to provide information regarding a

statement of estimated regulatory costs, or provide a proposal

for a lower cost regulatory alternative must do so in writing

within 21 days of this notice.

RULEMAKING AUTHORITY: 456.077, 456.079, 458.309,

458.331(5), 458.347(7)(f), (13) FS.

LAW IMPLEMENTED: 456.072, 456.077, 456.079, 458.331,

458.347(4)(e)1., (7)(f), (13) FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS

NOTICE, A HEARING WILL BE SCHEDULED AND

ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE

PROPOSED RULE IS: Claudia Kemp, J.D., Executive

Director, Board of Medicine/MQA, 4052 Bald Cypress Way,

Bin # C03, Tallahassee, Florida 32399-3253.

THE FULL TEXT OF THE PROPOSED RULE IS:

64B8-30.014 Citation Authority. In lieu of the disciplinary

procedures contained in Section 456.073, F.S., the offenses

enumerated in this rule may be disciplined by the issuance of a

citation. The citation shall include a requirement that the

licensee correct the offense, if possible, within a specified

period of time, impose whatever obligations will correct the

offense, and impose the prescribed penalty.

(1) through (2) No change.

(3) The following violations with accompanying penalty

may be disposed of by citation with the specified penalty:

VIOLATIONS PENALTY

(a) through (j) No change.

(k) Failure to consult the

Prescription Drug Monitoring

System as required by Section

893.055(8), F.S.

(Section 458.331(1)(g), F.S.)

First-time Citation – $100

fine.

Second-time Citation – $150

fine.

Third-time Citation -- $200

fine.

(4) – (5) No change.

Rulemaking Authority 456.077, 458.309, 458.347(7)(f), (13) FS. Law

Implemented 456.077, 458.331, 458.347(7)(f), (13) FS. History–New

3-3-02, Amended 5-19-03, 11-17-03, 5-4-04, 12-12-05, 8-2-06, 8-18-

09, 5-17-17, .

64B8-30.015 Disciplinary Guidelines.

(1) No change.

(2) Violations and Range of Penalties. In imposing

discipline upon physician assistant applicants and licensees, in

proceedings pursuant to Sections 120.57(1) and (2), F.S., the

Board shall act in accordance with the following disciplinary

guidelines and shall impose a penalty within the range

corresponding to the violations set forth below. The verbal

identification of offenses are descriptive only; the full language

of each statutory provision cited must be consulted in order to

determine the conduct included.

VIOLATIONS RECOMMENDED PENALTIES

First Offense Subsequent Offenses

(a) through (ll) No

change.

(mm) Engaging in a

pattern of practice

when prescribing

medicinal drugs or

controlled

substances which

demonstrates a lack

of reasonable skill

or safety to patients.

(Section

456.072(1)(gg),

F.S.)

(mm) From one

year reprimand to

probation to

revocation, and an

administrative

fine ranging from

$1,000.00 to

$10,000.00

$5,000.00, or

denial of

licensure.

(mm) From

suspension to be

followed by

probation, to

revocation or denial

of licensure, and an

administrative fine

ranging from

$2,500.00 to

$5,000.00 to

$10,000.00, or denial

of licensure.

(nn) to (ss) No

change.

(tt) Failure to

consult the

prescription drug

monitoring system,

as required by

Section 895.055(8),

F.S.

(Section

458.331(1)(g), F.S.)

(tt) From a letter

of concern to a

reprimand and an

administrative

fine of $1,000.00

to $2,500.00.

(tt) From a

reprimand to

revocation and an

administrative fine of

$2,500.00 to

$10,000.00

(3) through (4) No change.

Rulemaking Authority 456.079, 458.309, 458.331(5) FS. Law

Implemented 456.072, 456.079, 458.331(5), 458.347(4)(e)1., (7)(f)

FS. History–New 3-13-89, Formerly 21M-17.015, 61F6-17.015, 59R-

30.015, Amended 6-7-98, 4-9-01, 5-16-10, 3-26-12, 5-17-17, .

NAME OF PERSON ORIGINATING PROPOSED RULE:

Council on Physician Assistants

NAME OF AGENCY HEAD WHO APPROVED THE

PROPOSED RULE: Board of Medicine

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4353

DATE PROPOSED RULE APPROVED BY AGENCY

HEAD: August 3, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT

PUBLISHED IN FAR: September 6, 2018

DEPARTMENT OF HEALTH

Board of Optometry

RULE NO.: RULE TITLE:

64B13-18.002 Formulary of Topical Ocular Pharmaceutical

Agents

PURPOSE AND EFFECT: To add a topical ocular

pharmaceutical agent to the formulary.

SUMMARY: To update the formulary rule to add an additional

agent.

SUMMARY OF STATEMENT OF ESTIMATED

REGULATORY COSTS AND LEGISLATIVE

RATIFICATION:

The Agency has determined that this will not have an adverse

impact on small business or likely increase directly or indirectly

regulatory costs in excess of $200,000 in the aggregate within

one year after the implementation of the rule. A SERC has not

been prepared by the Agency.

The Agency has determined that the proposed rule is not

expected to require legislative ratification based on the

statement of estimated regulatory costs or if no SERC is

required, the information expressly relied upon and described

herein: During discussion of the economic impact of this rule at

its Board meeting, the Board concluded that this rule change

will not have any impact on licensees and their businesses or

the businesses that employ them. The rule will not increase any

fees, business costs, personnel costs, will not decrease profit

opportunities, and will not require any specialized knowledge

to comply. This change will not increase any direct or indirect

regulatory costs. Hence, the Board determined that a Statement

of Estimated Regulatory Costs (SERC) was not necessary and

that the rule will not require ratification by the Legislature. No

person or interested party submitted additional information

regarding the economic impact at that time.

Any person who wishes to provide information regarding a

statement of estimated regulatory costs, or provide a proposal

for a lower cost regulatory alternative must do so in writing

within 21 days of this notice.

RULEMAKING AUTHORITY: 463.005, 463.0055(2)(a) FS.

LAW IMPLEMENTED: 463.0055 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS

NOTICE, A HEARING WILL BE SCHEDULED AND

ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE

PROPOSED RULE IS: Anthony B. Spivey, Executive

Director, Board of Optometry, 4052 Bald Cypress Way, Bin #

C07, Tallahassee, Florida 32399-3257.

THE FULL TEXT OF THE PROPOSED RULE IS:

64B13-18.002 Formulary of Topical Ocular

Pharmaceutical Agents

(1) through (7) No change.

(8) ANTI-GLAUCOMA AGENTS

(a) through (e) No change.

(f) Rho Kinase Inhibitor - Netarsudil – 0.02%.

(9) No change.

Rulemaking Authority 463.005, 463.0055(2)(a) FS. Law Implemented

463.0055 FS. History–New 3-30-87, Amended 4-5-88, 5-7-90,

Formerly 21-18.002, Amended 5-10-92, 1-29-93, Formerly 21Q-

18.002, Amended 8-31-93, 7-30-94, Formerly 61F8-18.002, Amended

2-11-96, 4-21-96, 1-12-97, 6-8-97, Formerly 59V-18.002, Amended

6-15-00, 6-7-05, 6-10-06, 6-26-08, 10-16-08, 3-23-09, 6-28-09, 10-18-

09, 4-21-10, 12-26-10, 7-21-11, 11-11-12, 11-29-13, 12-9-13, 4-10-14,

8-14-15, 1-20-17, 8-31-18,_____.

NAME OF PERSON ORIGINATING PROPOSED RULE:

Board of Optometry

NAME OF AGENCY HEAD WHO APPROVED THE

PROPOSED RULE: Board of Optometry

DATE PROPOSED RULE APPROVED BY AGENCY

HEAD: June 22, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT

PUBLISHED IN FAR: September 4, 2018

DEPARTMENT OF HEALTH

Board of Osteopathic Medicine

RULE NOS.: RULE TITLES:

64B15-6.01051 Citation Authority

64B15-6.011 Disciplinary Guidelines

PURPOSE AND EFFECT: The proposed rule amendments are

intended to set forth citation violations and disciplinary

guidelines for the failure of physician assistants to consult the

prescription drug monitoring system. Additionally, the Rule

64B15-6.011 is being amended to change penalties for

prescribing medicinal drugs or controlled substances which

demonstrates a lack of reasonable skill or safety to patients.

SUMMARY: The proposed rule amendments to 64B15-

6.01051 set forth a first, second and third-time penalty for

physician assistants who fail to consult the prescription drug

monitoring system. The amendments to Rule 64B15-6.011 set

forth revised penalties for prescribing medicinal drugs or

controlled substances which demonstrates a lack of reasonable

skill or safety to patients; and set forth a penalty for failure to

consult the prescription drug monitoring system.

SUMMARY OF STATEMENT OF ESTIMATED

REGULATORY COSTS AND LEGISLATIVE

RATIFICATION:

The Agency has determined that this will not have an adverse

impact on small business or likely increase directly or indirectly

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4354

regulatory costs in excess of $200,000 in the aggregate within

one year after the implementation of the rule. A SERC has not

been prepared by the Agency.

The Agency has determined that the proposed rule is not

expected to require legislative ratification based on the

statement of estimated regulatory costs or if no SERC is

required, the information expressly relied upon and described

herein: During discussion of the economic impact of this rule at

its Board meeting, the Board concluded that this rule change

will not have any impact on licensees and their businesses or

the businesses that employ them. The rule will not increase any

fees, business costs, personnel costs, will not decrease profit

opportunities, and will not require any specialized knowledge

to comply. This change will not increase any direct or indirect

regulatory costs. Hence, the Board determined that a Statement

of Estimated Regulatory Costs (SERC) was not necessary and

that the rule will not require ratification by the Legislature. No

person or interested party submitted additional information

regarding the economic impact at that time.

Any person who wishes to provide information regarding a

statement of estimated regulatory costs, or provide a proposal

for a lower cost regulatory alternative must do so in writing

within 21 days of this notice.

RULEMAKING AUTHORITY: 456.077, 456.079, 459.005,

459.015(5), 459.022(7)(f), (12) FS.

LAW IMPLEMENTED: 456.072, 456.077, 459.015,

459.022(4)(e)1.,(7)(d), (f), (12) FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS

NOTICE, A HEARING WILL BE SCHEDULED AND

ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE

PROPOSED RULE IS: Kama Monroe, J.D., Executive

Director, Board of Osteopathic Medicine/MQA, 4052 Bald

Cypress Way, Bin # C06, Tallahassee, Florida 32399-3256.

THE FULL TEXT OF THE PROPOSED RULE IS:

64B15-6.01051 Citation Authority.

In lieu of the disciplinary procedures contained in Section

456.073, F.S., the offenses enumerated in this rule may be

disciplined by the issuance of a citation. The citation shall

include a requirement that the licensee correct the offense, if

possible, within a specified period of time, impose whatever

obligations will correct the offense, and impose the prescribed

penalty.

(1) Pursuant to Section 456.077, F.S., the Board sets forth

below those violations for which there is no substantial threat

to the public health, safety, and welfare; or, if there is a

substantial threat to the public health, safety, and welfare, such

potential for harm has been removed prior to the issuance of the

citation. Next to each violation is the penalty to be imposed. In

addition to any administrative fine imposed, the Respondent

may be required by the Department to pay the costs of

investigation.

(2) If the violation constituted a substantial threat to the

public health, safety, and welfare, such potential for harm must

have been removed prior to issuance of the citation.

(3) The following violations with accompanying penalty

may be disposed of by citation with the specified penalty:

VIOLATIONS PENALTY

(a) through (j) No change.

(k) Failure to consult the

Prescription Drug Monitoring

System as required by Section

893.055(8), F.S.

(Section 459.015(1)(g), F.S.)

First-time Citation –

$100 fine.

Second-time Citation

– $150 fine.

Third-time Citation -

- $200 fine.

(4) – (5) No change.

Rulemaking Authority 456.077, 459.005, 459.022(7)(f), (12) FS. Law

Implemented 456.077, 459.015, 459.022(7)(d), (f), (12) FS. History–

New 3-10-02, Amended 1-12-04, 5-4-04, 12-12-05, 8-2-06, 8-18-09,

5-17-17, .

64B15-6.011 Disciplinary Guidelines.

(1) Purpose. Pursuant to Section 456.072, F.S., the Boards

provide within this rule disciplinary guidelines which shall be

imposed upon physician assistant applicants or licensees whom

it regulates under Chapters 458 and 459, F.S. The purpose of

this rule is to notify such applicants and licensees of the ranges

of penalties which will routinely be imposed unless the Boards

find it necessary to deviate from the guidelines for the stated

reasons given within this rule. The ranges of penalties provided

below are based upon a single count violation of each provision

listed; for multiple counts of the violated provisions or a

combination of the violations the Boards shall consider a higher

penalty than that for a single, isolated violation. Each range

includes the lowest and highest penalty and all penalties falling

between, including continuing medical education (CME). The

purposes of the imposition of discipline are to punish the

applicants or licensees for violations and to deter them from

future violations; to offer opportunities for rehabilitation, when

appropriate; and to deter other applicants or licensees from

violations.

(2) Violations and Range of Penalties. In imposing

discipline upon physician assistant applicants and licensees, in

proceedings pursuant to Sections 120.57(1) and (2), F.S., the

Board shall act in accordance with the following disciplinary

guidelines and shall impose a penalty within the range

corresponding to the violations set forth below. The verbal

identification of offenses are descriptive only; the full language

of each statutory provision cited must be consulted in order to

determine the conduct included.

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4355

VIOLATIONS RECOMMENDED PENALTIES

First Offense Subsequent

Offenses

(a) through (ll) No

change.

(mm) Engaging in a

pattern of practice

when prescribing

medicinal drugs or

controlled

substances which

demonstrates a lack

of reasonable skill

or safety to patients.

(Section

456.072(1)(gg),

F.S.)

(mm) From one year

reprimand to

probation to

revocation, and an

administrative fine

ranging from

$1,000.00 to

$10,000.00

$5,000.00, or denial

of licensure.

(mm) From

suspension to be

followed by

probation, to

revocation or

denial of licensure,

and an

administrative fine

ranging from

$2,500.00 to

$5,000.00 to

$10,000.00, or

denial of licensure.

(nn) through (ss)

No change.

(tt) Failure to

consult the

prescription drug

monitoring system,

as required by

Section 895.055(8),

F.S.

(Section

459.015(1)(g), F.S.)

(tt) From a letter of

concern to a

reprimand and an

administrative fine

of $1,000.00 to

$2,500.00.

(tt) From a

reprimand to

revocation and an

administrative fine

of $2,500.00 to

$10,000.00

(3) through (4) No change.

Rulemaking Authority 456.079, 459.015(5) FS. Law Implemented

456.072, 456.079, 459.015(5), 459.022(4)(e)1., (7)(f) FS. History–

New 4-18-89, Formerly 21R-6.011, Amended 11-4-93, Formerly

61F9-6.011, 59W-6.011, Amended 6-7-98, 4-9-01, 7-13-03, 5-16-10,

3-26-12, 5-17-17, .

NAME OF PERSON ORIGINATING PROPOSED RULE:

Council on Physician Assistants

NAME OF AGENCY HEAD WHO APPROVED THE

PROPOSED RULE: Board of Osteopathic Medicine

DATE PROPOSED RULE APPROVED BY AGENCY

HEAD: August 24, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT

PUBLISHED IN FAR: September 6, 2018

DEPARTMENT OF HEALTH

Board of Osteopathic Medicine

RULE NOS.: RULE TITLES:

64B15-13.001 Continuing Education for Biennial Renewal

64B15-13.0025 Requirement for Continuing Education

Course on Prescribing Controlled

Substances

PURPOSE AND EFFECT: The proposed rule amendments are

intended to set forth additional entities approved by the Board

to provide the prescribing controlled substances course for

licensure renewal and to add additional entities to the recent

new rule requiring the course for prescribers prior to January

31, 2019.

SUMMARY: The proposed rule amendments set forth

additional entities approved by the Board to provide the

prescribing controlled substances course for licensure renewal.

Additionally, the amendment adds additional entities to the

recent new rule requiring the course for prescribers prior to

January 31, 2019.

SUMMARY OF STATEMENT OF ESTIMATED

REGULATORY COSTS AND LEGISLATIVE

RATIFICATION:

The Agency has determined that this will not have an adverse

impact on small business or likely increase directly or indirectly

regulatory costs in excess of $200,000 in the aggregate within

one year after the implementation of the rule. A SERC has not

been prepared by the Agency.

The Agency has determined that the proposed rule is not

expected to require legislative ratification based on the

statement of estimated regulatory costs or if no SERC is

required, the information expressly relied upon and described

herein: During discussion of the economic impact of this rule at

its Board meeting, the Board concluded that this rule change

will not have any impact on licensees and their businesses or

the businesses that employ them. The rule will not increase any

fees, business costs, personnel costs, will not decrease profit

opportunities, and will not require any specialized knowledge

to comply. This change will not increase any direct or indirect

regulatory costs. Hence, the Board determined that a Statement

of Estimated Regulatory Costs (SERC) was not necessary and

that the rule will not require ratification by the Legislature. No

person or interested party submitted additional information

regarding the economic impact at that time.

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4356

Any person who wishes to provide information regarding a

statement of estimated regulatory costs, or provide a proposal

for a lower cost regulatory alternative must do so in writing

within 21 days of this notice.

RULEMAKING AUTHORITY: 456.013, 456.0301, 459.005,

459.008(4) FS.

LAW IMPLEMENTED: 456.013, 456.0301, 456.031, 459.008

FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS

NOTICE, A HEARING WILL BE SCHEDULED AND

ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE

PROPOSED RULE IS: Kama Monroe, J.D., Executive

Director, Board of Osteopathic Medicine/MQA, 4052 Bald

Cypress Way, Bin # C06, Tallahassee, Florida 32399-3256.

THE FULL TEXT OF THE PROPOSED RULE IS:

64B15-13.001 Continuing Education for Biennial

Renewal.

Every person licensed pursuant to chapter 459, F.S., except

those licensed as physician assistants pursuant to section

459.022, F.S., shall be required to complete forty (40) hours of

continuing medical education courses approved by the Board in

the twenty-four (24) months preceding each biennial renewal

period as established by the Department. Continuing medical

education (CME) requirements for biennial renewal of

licensure are set forth in this rule.

(1)(a) For each biennial renewal, a licensee shall complete

a one (1) hour continuing medical education course in Florida

Laws and Rules/Professional and Medical Ethics, and a two (2)

hour course in Prevention of Medical Errors.

(b) through (d) No change.

(e) A licensee who is registered with the United States

Drug Enforcement Agency and is authorized to prescribe

controlled substances is required to complete a 2-hour course

on prescribing controlled substances at each biennial renewal

of licensure as required by section 456.0301, Florida Statutes.

The Board approves the controlled substance prescribing

courses offered by the Florida Medical Association, the Florida

Osteopathic Medical Association, the Florida Academy of

Family Physicians, and the Florida College of Emergency

Physicians, Baptist Health South Florida/Quality Network, and

InforMed, for the purpose of meeting this continuing education

requirement. The course may be offered in a distance learning

format.

(2) through (8) No change.

Rulemaking Authority 456.013, 456.0301, 459.005, 459.008(4) FS.

Law Implemented 456.013, 456.0301, 456.031, 459.008 FS. History–

New 10-23-79, Amended 1-29-86, Formerly 21R-13.01, Amended 12-

5-89, 4-8-91, 2-16-92, Formerly 21R-13.001, Amended 1-10-94,

Formerly 61F9-13.001, Amended 10-25-95, Formerly 59W-13.001,

Amended 1-19-98, 6-3-98, 4-14-99, 5-26-02, 5-10-04, 7-27-04, 2-9-

05, 2-14-06, 1-29-07, 5-10-09, 4-5-10, 11-6-12, 8-14-14, 8-21-16, 5-

17-18, 8-9-18, .

64B15-13.0025 Requirement for Continuing Education

Course on Prescribing Controlled Substances.

(1) No change.

(2) The Board approves the controlled substance

prescribing courses offered by the Florida Medical Association,

the Florida Osteopathic Medical Association, the Florida

Academy of Family Physicians, and the Florida College of

Emergency Physicians, Baptist Health South Florida/Quality

Network, and InforMed, for the purpose of meeting this

continuing education requirement. The course may be offered

in a distance learning format.

(3) through (4) No change.

Rulemaking Authority 456.0301(2) FS. Law Implemented 456.0301

FS. History–New 7-11-18, Amended .

NAME OF PERSON ORIGINATING PROPOSED RULE:

Board of Osteopathic Medicine

NAME OF AGENCY HEAD WHO APPROVED THE

PROPOSED RULE: Board of Osteopathic Medicine

DATE PROPOSED RULE APPROVED BY AGENCY

HEAD: August 24, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT

PUBLISHED IN FAR: September 5, 2018

DEPARTMENT OF HEALTH

Board of Osteopathic Medicine

RULE NO.: RULE TITLE:

64B15-19.007 Citations

PURPOSE AND EFFECT: The proposed rule amendment is

intended to set forth an additional violation which is appropriate

for the issuance of a citation.

SUMMARY: The proposed rule amendment sets forth a first

and second time citation for the failure of the designated

physician of a pain management clinic to notify the Board

within 10 days of terminating his or her employment with the

pain management clinic; or the failure of any physician

practicing in a pain management clinic to notify the Board of

his or her beginning or ending practice at a pain management

clinic.

SUMMARY OF STATEMENT OF ESTIMATED

REGULATORY COSTS AND LEGISLATIVE

RATIFICATION:

The Agency has determined that this will not have an adverse

impact on small business or likely increase directly or indirectly

regulatory costs in excess of $200,000 in the aggregate within

one year after the implementation of the rule. A SERC has not

been prepared by the Agency.

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4357

The Agency has determined that the proposed rule is not

expected to require legislative ratification based on the

statement of estimated regulatory costs or if no SERC is

required, the information expressly relied upon and described

herein: During discussion of the economic impact of this rule at

its Board meeting, the Board concluded that this rule change

will not have any impact on licensees and their businesses or

the businesses that employ them. The rule will not increase any

fees, business costs, personnel costs, will not decrease profit

opportunities, and will not require any specialized knowledge

to comply. This change will not increase any direct or indirect

regulatory costs. Hence, the Board determined that a Statement

of Estimated Regulatory Costs (SERC) was not necessary and

that the rule will not require ratification by the Legislature. No

person or interested party submitted additional information

regarding the economic impact at that time.

Any person who wishes to provide information regarding a

statement of estimated regulatory costs, or provide a proposal

for a lower cost regulatory alternative must do so in writing

within 21 days of this notice.

RULEMAKING AUTHORITY: 456.077 FS.

LAW IMPLEMENTED: 456.077 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS

NOTICE, A HEARING WILL BE SCHEDULED AND

ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE

PROPOSED RULE IS: Kama Monroe, J.D., Executive

Director, Board of Osteopathic Medicine/MQA, 4052 Bald

Cypress Way, Bin # C06, Tallahassee, Florida 32399-3256.

THE FULL TEXT OF THE PROPOSED RULE IS:

64B15-19.007 Citations.

(1) through (2) No change.

(3) The following violations with accompanying fines may

be disposed of by citation.

(a) through (v) No change.

(w) Failure of the designated physician of a pain

management clinic to notify the Board within 10 days of

terminating his or her employment with the pain management

clinic; or failure of any physician practicing in a pain

management clinic to notify the Board of his or her beginning

or ending practice at a pain management clinic, as required by

Section 459.0137(3)(e), F.S. The fine shall be $250 and the

submission of the required notice within 10 days for a first-time

violation. The fine shall be $500 and the submission of the

required notice within 10 days for a second-time violation.

(4) through (5) No change.

Rulemaking Authority 456.077 FS. Law Implemented 456.077 FS.

History–New 10-28-91, Amended 8-24-92, 11-17-92, Formerly 21R-

19.007, 61F9-19.007, 59W-19.007, Amended 11-27-97, 11-12-00, 1-

29-03, 7-13-03, 5-12-05, 4-15-10, 10-8-12, 8-13-15, 11-27-16, 8-9-18,

.

NAME OF PERSON ORIGINATING PROPOSED RULE:

Board of Osteopathic Medicine

NAME OF AGENCY HEAD WHO APPROVED THE

PROPOSED RULE: Board of Osteopathic Medicine

DATE PROPOSED RULE APPROVED BY AGENCY

HEAD: August 24, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT

PUBLISHED IN FAR: September 5, 2018

Section III

Notice of Changes, Corrections and

Withdrawals

DEPARTMENT OF AGRICULTURE AND CONSUMER

SERVICES

Division of Animal Industry

RULE NO.: RULE TITLE:

5C-24.003 Official Certificate of Veterinary Inspection

(OCVI)

NOTICE OF CHANGE

Notice is hereby given that the following changes have been

made to the proposed rule in accordance with subparagraph

120.54(3)(d)1., F.S., published in Vol. 44 No. 127, June 29,

2018 issue of the Florida Administrative Register.

5C-24.003 Official Certificate of Veterinary Inspection

(OCVI)

(1) through (3) No change.

(4) Dogs, Cats and Other Non-Livestock Species.

(a) No change.

(b) OCVI for Sale of Dog or Cat. The OCVI required to

transfer the ownership of a dog or cat by sale within Florida is

the Official Certificate of Veterinary Inspection for Intrastate

Sale of Dog or Cat, FDACS-09085 Rev. 01/18. The Official

Certificate of Veterinary Inspection for Intrastate Sale of a Dog

or Cat, FDACS-09085 Rev. 01/18, as incorporated in Rule 5C-

27.001, F.A.C.

(c) No change.

(5) Forms. The following forms are hereby incoporated by

reference and available online as indicated. Copies may also be

obtained from the Florida Department of Agriculture and

Consumer Services, Division of Animal Industry, 407 South

Calhoun Street, Room 323, Mayo Building, Tallahassee,

Florida 32399-0800.

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4358

(a) The Official Equine Certificate of Veterinary

Inspection, FDACS-09002 Rev. 8/1804/17, a sample of which

is available online at

http://www.flrules.org/Gateway/reference.asp?No=Ref-

XXXX.

(b) through (c) No change.

(d) The Official Certificate of Veterinary Inspection for

Intrastate Sale of a Dog or Cat, FDACS-09085 Rev. 01/18, as

incorporated in Rule 5C-27.001, F.A.C.

(e) through (f) redesignated (d) through (e) No change.

Rulemaking Authority 585.002(4), (5), 585.08(2)(a), 585.145(2),

585.15 FS. Law Implemented 585.002(5), 585.08(1), (2), 585.145(1),

(2), (3), 585.155, 828.29 FS. History–New 7-13-99, Amended 4-14-

02, 8-31-08, .

Section IV

Emergency Rules

NONE

Section V

Petitions and Dispositions Regarding Rule

Variance or Waiver

WATER MANAGEMENT DISTRICTS

South Florida Water Management District

RULE NO.: RULE TITLE:

40E-6.011 Policy and Purpose

The South Florida Water Management District (District) hereby

gives notice: On September 13, 2018, the District's Governing

Board issued SFWMD Order No. 2018-040-DAO-ROW to

Florida Power & Light Co. (Application No. 18-0420-5). The

petition for waiver was received by the District on July 12,

2018. Notice of receipt of the petition requesting the waiver was

published in the Florida Administrative Weekly, Vol. 44, No.

139 on July 18, 2018. No public comment was received. This

Order provides a waiver of the District's criteria for utilization

of the District allow installation of an aerial utility project

within the north right of way of the Golden Gate Main Canal;

Section 13, Township 49 South, Range 26 East; Collier County.

Specifically, the Order grants a waiver from subsections 40E-

6.011(4) and (6), Fla. Admin. Code, and the Basis of Review

for Use or Occupancy of the Works or Lands of the District,

incorporated by reference in subsection 40E-6.091(1), Fla.

Admin. Code, which governs the placement of permanent and

semi-permanent above-ground structures within 40 feet of top

of canal bank within works or lands of the District. Generally,

the Order sets forth the basis of the Governing Board decision

to grant the waiver as follows: 1) the proposed installation will

not interfere with the District's current ability to perform

necessary construction, alteration, operation, and routine

maintenance activities; and 2) the Order granting a waiver from

the subject rule is based upon a substantial hardship.

A copy of the Order or additional information may be obtained

by contacting: Juli Russell at the South Florida Water

Management District, 3301 Gun Club Road, MSC 1410, West

Palm Beach, FL 33406-4680; telephone: (561)682-6268; or by

email at: [email protected].

WATER MANAGEMENT DISTRICTS

South Florida Water Management District

RULE NO.: RULE TITLE:

40E-6.011 Policy and Purpose

The South Florida Water Management District (District) hereby

gives notice: On September 13, 2018, the District's Governing

Board issued SFWMD Order No. 2018-041-DAO-ROW to R.J.

Marina Holdings, LLC (Application No. 14-0505-1). The

petition for waiver was received by the District on June 22,

2018. Notice of receipt of the petition requesting the waiver was

published in the Florida Administrative Weekly, Vol. 44, No.

125 on June 27, 2018. No public comment was received. This

Order provides a waiver of the District's criteria for utilization

of the District allow existing facilities associated with the

lifeboat training facility to remain within the west right of way

of the C-10 Canal; Section 33, Township 50 South, Range 42

East; Broward County. Specifically, the Order grants a waiver

from subsections 40E-6.011(4) and (6), Fla. Admin. Code, and

the Basis of Review for Use or Occupancy of the Works or

Lands of the District, incorporated by reference in subsection

40E-6.091(1), Fla. Admin. Code, which governs the placement

of permanent and semi-permanent above-ground structures

within 40 feet of top of canal bank within works or lands of the

District. Generally, the Order sets forth the basis of the

Governing Board decision to grant the waiver as follows: 1) the

proposed installation will not interfere with the District's

current ability to perform necessary construction, alteration,

operation, and routine maintenance activities; and 2) the Order

granting a waiver from the subject rule is based upon a

substantial hardship.

A copy of the Order or additional information may be obtained

by contacting: Juli Russell at the South Florida Water

Management District, 3301 Gun Club Road, MSC 1410, West

Palm Beach, FL 33406-4680; telephone: (561)682-6268; or by

email at: [email protected].

DEPARTMENT OF BUSINESS AND PROFESSIONAL

REGULATION

Division of Hotels and Restaurants

RULE NO.: RULE TITLE:

61C-1.004 General Sanitation and Safety Requirements

The Florida Department of Business and Professional

Regulation, Division of Hotels and Restaurants hereby gives

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4359

notice: On September 11, 2018 the Division of Hotels and

Restaurants received a Petition for a Routine Variance for

paragraph 61C-1.004(2)(a), Florida Administrative Code,

subsection 61C-4.010(7), Florida Administrative Code and

subsection 61C-4.010(6), Florida Administrative Code, and

Section 6-40.11. 2009 FDA Food Code from 3 Kings Café &

Catering Inc. located in Fernandina Beach. The above

referenced F.A.C. addresses the requirement that at least one

accessible bathroom be provided for use by customers and

employees. They are requesting to utilize bathrooms located on

a different level.

The Petition for this variance was published in Vol. 44/178 on

September 12, 2018. The Order for this Petition was signed and

approved on September 20, 2018. After a complete review of

the variance request, the Division finds that the application of

this Rule will create a financial hardship to the food service

establishment. Furthermore, the Division finds that the

Petitioner meets the burden of demonstrating that the

underlying statute has been achieved by the Petitioner ensuring

the public bathrooms located on the first floor are maintained in

a clean and sanitary manner and are provided with hot and cold

running water under pressure, soap, approved hand drying

devices, handwash sign and are available during all hours of

operation. The Petitioner shall also ensure that directional

signage is installed in the main restaurant area clearly stating

the location of the bathrooms.

A copy of the order or additional information may be obtained

by contacting: [email protected]

Division of Hotels and Restaurants, 2601 Blair Stone Road,

Tallahassee, Florida 32399-1011.

DEPARTMENT OF BUSINESS AND PROFESSIONAL

REGULATION

Division of Hotels and Restaurants

RULE NO.: RULE TITLE:

61C-4.010 Sanitation and Safety Requirements

The Florida Department of Business and Professional

Regulation, Division of Hotels and Restaurants hereby gives

notice:

On August 30, 2018 the Division of Hotels and Restaurants

received a Petition for a Routine Variance for paragraph 61C-

1.004(2)(a), Florida Administrative Code, subsection 61C-

4.010(7), Florida Administrative Code and subsection 61C-

4.010(6), Florida Administrative Code, and Section 6-40.11.

2009 FDA Food Code from La Chefette Restaurant Group LLC

located in Miami. The above referenced F.A.C. addresses the

requirement that at least one accessible bathroom be provided

for use by customers and employees. They are requesting to

utilize bathrooms located on a different level.

The Petition for this variance was published in Vol. 44/171 on

August 31, 2018. The Order for this Petition was signed and

approved on September 20, 2018. After a complete review of

the variance request, the Division finds that the application of

this Rule will create a financial hardship to the food service

establishment. Furthermore, the Division finds that the

Petitioner meets the burden of demonstrating that the

underlying statute has been achieved by the Petitioner ensuring

the public bathrooms located on the second floor are maintained

in a clean and sanitary manner and are provided with hot and

cold running water under pressure, soap, approved hand drying

devices, handwash sign and are available during all hours of

operation. The Petitioner shall also ensure that directional

signage is installed in the main restaurant area clearly stating

the location of the bathrooms.

A copy of the order or additional information may be obtained

by contacting: [email protected], Division

of Hotels and Restaurants, 2601 Blair Stone Road, Tallahassee,

Florida 32399-1011.

DEPARTMENT OF BUSINESS AND PROFESSIONAL

REGULATION

Division of Hotels and Restaurants

RULE NO.: RULE TITLE:

61C-1.004 General Sanitation and Safety Requirements

The Florida Department of Business and Professional

Regulation, Division of Hotels and Restaurants hereby gives

notice:

On September 11, 2018 the Division of Hotels and Restaurants

received a Petition for an Emergency Variance for paragraph

61C-1.004(1)(a), Florida Administrative Code and subsection

5-202.11(A), 2009 FDA Food Code from The Frozen Dragon

located in Pensacola. The above referenced F.A.C. addresses

the requirement that each establishment have an approved

plumbing system installed to transport potable water and

wastewater. They are requesting to utilize holding tanks to

provide potable water and to collect wastewater at the

handwash sink and the three compartment sink.

The Petition for this variance was published in Vol. 44/178 on

September 12, 2018. The Order for this Petition was signed and

approved on September 20, 2018. After a complete review of

the variance request, the Division finds that the application of

this Rule will create a financial hardship to the food service

establishment. Furthermore, the Division finds that the

Petitioner meets the burden of demonstrating that the

underlying statute has been achieved by the Petitioner ensuring

the wastewater holding tank for the handwash sink and the three

compartment sink is emptied at a frequency as to not create a

sanitary nuisance; and potable water provided must come from

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4360

an approved source and be protected from contamination during

handling. The Petitioner shall also ensure that the handwash

sink and the three compartment sink is provided with hot and

cold running water under pressure, and that the handwash sink

is provided with soap, an approved hand drying device and a

handwashing sign.

A copy of the order or additional information may be obtained

by contacting: [email protected]

Division of Hotels and Restaurants, 2601 Blair Stone Road,

Tallahassee, Florida 32399-1011.

DEPARTMENT OF BUSINESS AND PROFESSIONAL

REGULATION

Board of Professional Engineers

RULE NO.: RULE TITLE:

61G15-20.002 Experience

NOTICE IS HEREBY GIVEN that on September 14, 2018, the

Board of Professional Engineers, received a petition for

variance or waiver filed by Caitlin Carnley, regarding the

requirement of subparagraph 61G15-20.002(1)(b)3, F.A.C.,

that to be creditable, experience must be acquired from full-

time work. Comments on this petition should be filed with the

Board of Professional Engineers, 2639 North Monroe Street,

Suite B-112, Tallahassee, FL 32303, within 14 days of

publication of this notice.

A copy of the Petition for Variance or Waiver may be obtained

by contacting: Zana Raybon, Executive Director, at the above

address or telephone: (850)521-0050 or by email:

[email protected].

Section VI

Notice of Meetings, Workshops and Public

Hearings

DEPARTMENT OF LAW ENFORCEMENT

The Criminal and Juvenile Justice Information Systems (CJJIS)

Council Criminal Justice Data Transparency Work Group

announces a telephone conference call to which all persons are

invited.

DATE AND TIME: October 3, 2018, 1:30 p.m., ET

PLACE: Conference Call

GENERAL SUBJECT MATTER TO BE CONSIDERED:

Discussion on data elements and next steps.

A copy of the agenda may be obtained by contacting:

[email protected].

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 3 days before the workshop/meeting by

contacting: [email protected]. If you are hearing or

speech impaired, please contact the agency using the Florida

Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770

(Voice).

For more information, you may contact:

[email protected].

DEPARTMENT OF REVENUE

Property Tax Oversight Program

The DEPARTMENT OF REVENUE announces a public

meeting to which all persons are invited.

DATE AND TIME: Tuesday, October 2, 2018, 9:30 a.m., ET

PLACE: 2450 Shumard Oak Boulevard, Building 2, Room

1220, Tallahassee, Florida 32399

The meeting will be conducted using communications media

technology, specifically a telephone conference call. Persons

interested in attending by phone may do so by calling

1(866)899-4679 and entering participant code 945-784-021.

The public point of access to the call is 2450 Shumard Oak

Blvd, Building Two, Room 1220, Tallahassee, Florida 32399.

GENERAL SUBJECT MATTER TO BE CONSIDERED: The

Department will present applications for the Certified Florida

Evaluator and Certified Cadastralist of Florida designations.

Please refer to the Certified Florida Appraisers Admissions and

Certifications Committee Agenda and Materials on the

Department’s website at

http://floridarevenue.com/property/Pages/Cofficial_Training.a

spx before attending the meeting.

A copy of the agenda may be obtained by contacting: Kelly

McLane, Property Tax Oversight Program, Department of

Revenue, PO Box 3294, Tallahassee, FL 32315-3294,

(850)941-6024, [email protected]. Parties

may also submit written materials they intend to offer during

the meeting to Kelly McLane.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 48 hours before the workshop/meeting by

contacting: Kelly McLane at (850)941-6024 or

[email protected]. If you are hearing or

speech impaired, please contact the agency using the Florida

Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770

(Voice).

If any person decides to appeal any decision made by the Board

with respect to any matter considered at this meeting or hearing,

he/she will need to ensure that a verbatim record of the

proceeding is made, which record includes the testimony and

evidence from which the appeal is to be issued.

For more information, you may contact: Kelly McLane,

Property Tax Oversight Program, Department of Revenue, PO

Box 3294, Tallahassee, FL 32315-3294, (850)941-6024,

[email protected].

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4361

DEPARTMENT OF REVENUE

Property Tax Oversight Program

The DEPARTMENT OF REVENUE announces a public

meeting to which all persons are invited.

DATE AND TIME: Tuesday, October 2, 2018, 10:30 a.m., ET

PLACE: 2450 Shumard Oak Boulevard, Building 2, Room

1220, Tallahassee, Florida 32399

The meeting will be conducted using communications media

technology, specifically a telephone conference call. Persons

interested in attending by phone may do so by calling

1(866)899-4679 and entering participant code 280-776-005.

The public point of access to the call is 2450 Shumard Oak

Blvd, Building Two, Room 1220, Tallahassee, Florida 32399.

GENERAL SUBJECT MATTER TO BE CONSIDERED: The

Department will present applications for the Certified Florida

Collector Assistant designations. Please refer to the Certified

Florida Collectors Admissions and Certifications Committee

Agenda and Materials on the Department’s website at

http://floridarevenue.com/property/Pages/Cofficial_Training.a

spx before attending the meeting.

A copy of the agenda may be obtained by contacting: Kelly

McLane, Property Tax Oversight Program, Department of

Revenue, PO Box 3294, Tallahassee, FL 32315-3294,

(850)941-6024, [email protected]. Parties

may also submit written materials they intend to offer during

the meeting to Kelly McLane.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 48 hours before the workshop/meeting by

contacting: Kelly McLane at (850)941-6024 or

[email protected]. If you are hearing or

speech impaired, please contact the agency using the Florida

Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770

(Voice).

If any person decides to appeal any decision made by the Board

with respect to any matter considered at this meeting or hearing,

he/she will need to ensure that a verbatim record of the

proceeding is made, which record includes the testimony and

evidence from which the appeal is to be issued.

For more information, you may contact: Kelly McLane,

Property Tax Oversight Program, Department of Revenue, PO

Box 3294, Tallahassee, FL 32315-3294, (850)941-6024,

[email protected].

FLORIDA COMMISSION ON OFFENDER REVIEW

The Florida Commission on Offender Review announces a

public meeting to which all persons are invited.

DATE AND TIME: Thursday, October 4, 2018, 9:00 a.m.

PLACE: Florida Commission on Offender Review, 4070

Esplanade Way, Tallahassee, FL 32399-2450

GENERAL SUBJECT MATTER TO BE CONSIDERED:

Regularly scheduled Commission Business Meeting.

A copy of the agenda may be obtained by contacting: Ryan

Schenck, Office of Commissioner David Wyant, (850)487-

1978, [email protected].

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 2 days before the workshop/meeting by

contacting: Ryan Schenck, Office of Commissioner David

Wyant, (850)487-1978, [email protected]. If you

are hearing or speech impaired, please contact the agency using

the Florida Relay Service, 1(800)955-8771 (TDD) or

1(800)955-8770 (Voice).

REGIONAL PLANNING COUNCILS

Northeast Florida Regional Planning Council

The Northeast Florida Regional Council announces a public

meeting to which all persons are invited.

DATE AND TIME: October 4, 2018, 9:30 a.m., PB&F Policy

Committee meeting; 10:00 a.m., Board of Directors meeting;

Legislative Policy Committee meeting immediately following

the Board meeting

PLACE: 100 Festival Park Avenue, Jacksonville, FL 32202.

GENERAL SUBJECT MATTER TO BE CONSIDERED:

Regular Meeting.

A copy of the agenda may be obtained by contacting: (904)279-

0880.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 5 days before the workshop/meeting by

contacting: (904)279-0880. If you are hearing or speech

impaired, please contact the agency using the Florida Relay

Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).

REGIONAL PLANNING COUNCILS

Southwest Florida Regional Planning Council

The Southwest Florida Regional Planning Council announces a

public meeting to which all persons are invited.

DATE AND TIMES: October 11, 2018, 9:00 a.m., Relevancy

Committee; 11:00 a.m. (Promise Zone Steering Committee)

PLACE: SWFRPC Office, 1400 Colonial Blvd., Suite 1, Fort

Myers, FL 33907

GENERAL SUBJECT MATTER TO BE CONSIDERED:

SWFRPC Relevancy Committee meeting, 9:00 a.m.

SWFRPC Promise Zone Steering Committee meeting at 11:00

a.m.

A copy of the agenda may be obtained by contacting: Margaret

Wuerstle at [email protected] or (239)938-1813, ext. 222.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4362

participate in this workshop/meeting is asked to advise the

agency at least 48 hours before the workshop/meeting by

contacting: Margaret Wuerstle at [email protected] or

(239)938-1813, ext. 222. If you are hearing or speech impaired,

please contact the agency using the Florida Relay Service,

1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).

If any person decides to appeal any decision made by the Board

with respect to any matter considered at this meeting or hearing,

he/she will need to ensure that a verbatim record of the

proceeding is made, which record includes the testimony and

evidence from which the appeal is to be issued.

For more information, you may contact: Margaret Wuerstle at

[email protected] or (239)938-1813, ext. 222.

WATER MANAGEMENT DISTRICTS

Southwest Florida Water Management District

The Southwest Florida Water Management District announces

a public meeting to which all persons are invited.

DATE AND TIME: October 3, 2018, 9:00 a.m.

PLACE: 7601 HWY 301 N, Tampa, FL 33637

GENERAL SUBJECT MATTER TO BE CONSIDERED:

Regular monthly meeting to obtain feedback from interested

persons on current pending permit applications. The agenda is

available at www.swfwmd.state.fl.us/about/calendar/month.

A copy of the agenda may be obtained by contacting: Justin J.

Eddy, 1(813)985-7481, ext. 2097.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 5 days before the workshop/meeting by

contacting: SWFWMD, Human Resources Bureau Chief at

1(800)423-1476, ext. 4701; TDD (FL only) 1(800)231-6103 or

email: [email protected]. If you are

hearing or speech impaired, please contact the agency using the

Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-

8770 (Voice).

DEPARTMENT OF ENVIRONMENTAL PROTECTION

The Siting Coordination Office announces a hearing to which

all persons are invited.

DATES AND TIMES: November 6, 2018, 9:00 a.m. and

continuing to November 9, 2018, as necessary. Testimony from

the public will be received on November 7, 2018, 6:00 p.m. –

9:00 p.m.

PLACE: Quality Inn & Suites Conference Center, Pasco Room,

5316 US 19 North, New Port Richey, Florida 34652.

GENERAL SUBJECT MATTER TO BE CONSIDERED:

Administrative Law Judge E. Gary Early will conduct a hearing

to consider the environmental effects and any other appropriate

matters regarding whether to approve the site certification of

the proposed Shady Hills Energy Center LLC, Shady Hills

Combined Cycle Facility Power Plant Siting Application No.

PA18-59, OGC Case No. 18-0119, Division of Administrative

Hearings Case No. 18-000995EPP pursuant to the Florida

Electrical Power Plant Siting Act, Sections 403.501-.518,

Florida Statutes (F.S.). Following the hearing, Judge E. Gary

Early will prepare a Recommended Order for submission to and

final action by the Governor and Cabinet acting as the Siting

Board. Pursuant to paragraph 403.508(3)(a), F.S., parties to the

proceeding shall include the applicant, the Public Service

Commission, the Department of Economic Opportunity, the

Fish and Wildlife Conservation Commission, the Southwest

Florida Water Management District, the Department of

Environmental Protection, the Department of Transportation,

and Pasco County. Any party listed in paragraph 403.508(3)(a),

F.S., other than the Department of Environmental Protection or

the applicant may waive its right to participate in these

proceedings if such party fails to file a notice of its intent to be

a party on or before the 90th day prior to the certification

hearing. In addition, notwithstanding the provisions of Chapter

120, F.S., upon the filing with the administrative law judge of a

notice of intent to be a party no later than 75 days after the

application is filed, the following shall also be parties to the

proceeding: any agency not listed in paragraph 403.508(3)(a),

F.S., as to matters within its jurisdiction; any domestic

nonprofit corporation or association formed, in whole or in part,

to promote conservation or natural beauty, to protect the

environment, personal health, or other biological values; to

preserve historical sites; to promote consumer interests; to

represent labor, commercial, or industrial groups; or to promote

comprehensive planning or orderly development of the area in

which the proposed electrical power plant is to be located. Other

parties may include any person, including those persons listed

herein who have failed to timely file a notice of intent to be a

party, whose substantial interests are affected and being

determined by the proceeding and who timely file a motion to

intervene pursuant to Chapter 120, F.S., and applicable rules.

Intervention pursuant to Section 403.508(3)(e), F.S., may be

granted at the discretion of the designated administrative law

judge and upon such conditions as he or she may prescribe any

time prior to 30 days before the commencement of the

certification hearing. Motions to intervene must be filed

(received) with Administrative Law Judge E. Gary Early,

Division of Administrative Hearings, The DeSoto Building,

1230 Apalachee Parkway, Tallahassee, Florida 32399-1550, at

least 30 days prior to commencement of the certification

hearing. The certification hearing may be cancelled in

accordance with Section 403.508(6)(a), F.S.; “No earlier than

29 days prior to the conduct of the certification hearing, the

department or the applicant may request that the administrative

law judge cancel the certification hearing and relinquish

jurisdiction to the department if all parties to the proceeding

stipulate that there are no disputed issues of fact or law to be

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4363

raised at the certification hearing, and if sufficient time remains

for the applicant and the department to publish public notices

of the cancellation of the hearing at least 3 days prior to the

scheduled date of the hearing.”

A copy of the agenda may be obtained by contacting: Amanda

Dyer, Case Manager, Bob Martinez Center, 2600 Blair Stone

Road, M.S. 5500, Tallahassee, Florida 32399, (850)717-9000.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 48 hours before the workshop/meeting by

contacting: Amanda Dyer, Bob Martinez Center, 2600 Blair

Stone Road, M.S. 5500, Tallahassee, Florida 32399, (850)717-

9000. If you are hearing or speech impaired, please contact the

agency using the Florida Relay Service, 1(800)955-8771

(TDD) or 1(800)955-8770 (Voice).

For more information, you may contact: Amanda Dyer, Bob

Martinez Center, 2600 Blair Stone Road, M.S. 5500,

Tallahassee, Florida 32399, (850)717-9000.

DEPARTMENT OF ENVIRONMENTAL PROTECTION

Division of Recreation and Parks

The Florida Department of Environmental Protection, Division

of Recreation and Parks, announces a public meeting to which

all persons are invited.

DATE AND TIME: Wednesday, October 3, 2018, 9:00 a.m. –

12:00 Noon

PLACE: Ravine Gardens State Park Civic Center, 1600 Twigg

Street, Palatka, Florida 32177

GENERAL SUBJECT MATTER TO BE CONSIDERED:

Discussion of the proposed unit management plan update for

Dunns Creek State Park with the advisory group members.

A copy of the agenda may be obtained by contacting: Terri

Newmans, Park Manager, Dunns Creek State Park, c/o Ravine

Gardens State Park, 1600 Twigg Street, Palatka, Florida 32177,

PH#: (386)329-3721, FAX#: (386)329-3718 or email

[email protected].

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 48 hours before the workshop/meeting by

contacting: Terri Newmans, as listed above. If you are hearing

or speech impaired, please contact the agency using the Florida

Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770

(Voice).

DEPARTMENT OF ENVIRONMENTAL PROTECTION

Division of Recreation and Parks

The Florida Department of Environmental Protection, Division

of Recreation and Parks, announces a public meeting to which

all persons are invited.

DATE AND TIME: Tuesday, October 2, 2018, 5:30 p.m. – 7:30

p.m.

PLACE: Ravine Gardens State Park Civic Center, 1600 Twigg

Street, Palatka, Florida 32177

GENERAL SUBJECT MATTER TO BE CONSIDERED: An

opportunity for the public to provide input on the ten-year

management plan update for Dunns Creek State Park.

A copy of the agenda may be obtained by contacting: Terri

Newmans, Park Manager, Dunns Creek State Park, c/o Ravine

Gardens State Park, 1600 Twigg Street, Palatka, Florida 32177,

PH# (386)329-3721, FAX# (386)329-3718 or email

[email protected].

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 48 hours before the workshop/meeting by

contacting: Terri Newmans, as listed above. If you are hearing

or speech impaired, please contact the agency using the Florida

Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770

(Voice).

FLORIDA HOUSING FINANCE CORPORATION

The Florida Housing Finance Corporation announces a public

meeting to which all persons are invited.

DATE AND TIME: October 25, 2018, 4:00 p.m.

PLACE: Sheraton Bay Point, 4114 Jan Cooley Drive, Panama

City Beach, FL 32408

GENERAL SUBJECT MATTER TO BE CONSIDERED:

1. The Committee will meet regarding the general business of

the Committee.

2. Such other matters as may be included on the Agenda for the

October 25, 2018, Audit Committee Meeting.

A copy of the agenda may be obtained by contacting:

Approximately two days prior to the meeting by contacting

Sheila Freaney, Board Liaison, Florida Housing Finance

Corporation, 227 North Bronough Street, Suite 5000,

Tallahassee, Florida 32301-1329, phone number: (850)488-

4197 or by visiting the Corporation’s website at

www.floridahousing.org.

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4364

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 5 days before the workshop/meeting by

contacting: Sheila Freaney at the Florida Housing Finance

Corporation at (850)488-4197.

If any person decides to appeal any decision made by the

Corporation with respect to any matter considered at this

meeting, he or she will need a record of the proceedings, and

for such purpose, he or she may need to ensure that a verbatim

record of the proceedings be made, which record includes the

testimony and evidence upon which the appeal is to be based.

If you are hearing or speech impaired, please contact the agency

using the Florida Relay Service, 1(800)955-8771 (TDD) or

1(800)955-8770 (Voice).

FLORIDA HOUSING FINANCE CORPORATION

The FHFC III, Inc. announces a public meeting to which all

persons are invited.

DATE AND TIME: October 26, 2018, 11:00 a.m. or upon

adjournment of the FHFC II, Inc. Board of Directors meeting,

until adjourned

PLACE: Sheraton Bay Point, 4114 Jan Cooley Drive, Panama

City Beach, FL 32408

GENERAL SUBJECT MATTER TO BE CONSIDERED:

1. Conduct business necessary for the organization of FHFC III,

INC.

2. Consider adopting resolutions delegating operational

authority to the Executive Director.

3. Consideration of all necessary actions with regard to any

property owned or held by FHFC III, Inc.

4. Consideration of approval of underwriters for inclusion on

approved master list and teams.

5. Consideration of all necessary actions for initiating new rules

or rule amendments on an emergency or non-emergency basis.

6. Consideration of status, workouts, or modifications for

existing projects.

7. Consideration of matters relating to the statutory purpose of

FHFC III, Inc., to provide safe and sanitary housing that is

affordable for the residents of Florida.

8. Such other matters as may be included on the Agenda for the

October 26, 2018, Board Meeting.

A copy of the agenda may be obtained by contacting:

Approximately two days prior to the meeting by contacting

Sheila Freaney, Board Liaison, Florida Housing Finance

Corporation, 227 North Bronough Street, Suite 5000,

Tallahassee, Florida 32301-1329, phone number: (850)488-

4197 or by visiting the Corporation’s website at

www.floridahousing.org.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 5 days before the workshop/meeting by

contacting: Sheila Freaney at the Florida Housing Finance

Corporation at (850)488-4197.

If any person decides to appeal any decision made by FHFC III,

Inc., with respect to any matter considered at this meeting, he

or she will need a record of the proceedings, and for such

purpose, he or she may need to ensure that a verbatim record of

the proceedings be made, which record includes the testimony

and evidence upon which the appeal is to be based. If you are

hearing or speech impaired, please contact the agency using the

Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-

8770 (Voice).

FLORIDA HOUSING FINANCE CORPORATION

The FHFC II, INC. announces a public meeting to which all

persons are invited.

DATE AND TIME: October 26, 2018, 11:00 a.m. or upon

adjournment of the Florida Housing Finance Corporation Board

of Directors meeting, until adjourned

PLACE: Sheraton Bay Point, 4114 Jan Cooley Drive, Panama

City Beach FL 32408

GENERAL SUBJECT MATTER TO BE CONSIDERED:

1. Conduct business necessary for the organization of FHFC II,

INC.

2. Consider adopting resolutions delegating operational

authority to the Executive Director.

3. Consideration of all necessary actions with regard to any

property owned or held by FHFC II, Inc.

4. Consideration of approval of underwriters for inclusion on

approved master list and teams.

5. Consideration of all necessary actions for initiating new rules

or rule amendments on an emergency or non-emergency basis.

6. Consideration of status, workouts, or modifications for

existing projects.

7. Consideration of matters relating to the statutory purpose of

FHFC II, Inc., to provide safe and sanitary housing that is

affordable for the residents of Florida.

8. Such other matters as may be included on the Agenda for the

October 26, 2018, Board Meeting.

A copy of the agenda may be obtained by contacting:

Approximately two days prior to the meeting by contacting

Sheila Freaney, Board Liaison, Florida Housing Finance

Corporation, 227 North Bronough Street, Suite 5000,

Tallahassee, Florida 32301-1329, phone number: (850)488-

4197 or by visiting the Corporation’s website at

www.floridahousing.org.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 5 days before the workshop/meeting by

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4365

contacting: Sheila Freaney at the Florida Housing Finance

Corporation at (850)488-4197.

If any person decides to appeal any decision made by FHFC II,

Inc., with respect to any matter considered at this meeting, he

or she will need a record of the proceedings, and for such

purpose, he or she may need to ensure that a verbatim record of

the proceedings be made, which record includes the testimony

and evidence upon which the appeal is to be based. If you are

hearing or speech impaired, please contact the agency using the

Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-

8770 (Voice).

FLORIDA HOUSING FINANCE CORPORATION

The Florida Housing Finance Corporation announces a public

meeting to which all persons are invited.

DATE AND TIME: October 26, 2018, 8:30 a.m. until

adjourned

PLACE: Sheraton Bay Point, 4114 Jan Cooley Drive, Panama

City Beach, FL 32408

GENERAL SUBJECT MATTER TO BE CONSIDERED:

1. Consider financing and acknowledgement resolutions for

various multifamily developments, under any multifamily

program, including the ranking of developments.

2. Consider appointment of professionals including but not

limited to trustee and/or originator/servicer for upcoming

and/or past multifamily programs and single-family programs.

3. Consider approval of all bond documents for and terms of all

upcoming single-family and multifamily bond sales, including

those secured by third-party guarantors, letters-of-credit,

insurance or other mechanisms.

4. Consider adopting resolutions authorizing negotiated or

competitive sale of bonds on various single-family and

multifamily issues.

5. Consider directing Staff to submit summaries of various

TEFRA/Public Hearings to the Governor.

6. Consideration of policy issues concerning ongoing and

upcoming single-family bond issues including initiation of

request for proposals on an emergency basis, and structuring

new issues.

7. Consideration of all necessary actions with regard to the

Multifamily Bond Program.

8. Consideration of approval of underwriters for inclusion on

approved master list and teams.

9. Consideration of all necessary actions with regard to the

HOME Rental Program.

10. Consideration of all necessary actions with regard to the HC

(Housing Credits) Program.

11. Consideration of all necessary actions with regard to the

SAIL (State Apartment Incentive Loan) Program.

12. Consideration of all necessary actions with regard to the

SHIP (State Housing Initiatives Partnership) Program.

13. Consideration of all necessary actions with regard to the

PLP (Predevelopment Loan) Program.

14. Consideration of all necessary actions with regard to the

Homeownership Programs.

15. Consideration of all necessary actions for initiating new

rules or rule amendments on an emergency or non-emergency

basis.

16. Consideration of Appeals from Requests for Applications

funding selection with entry of final orders.

17. Consideration of workouts or modifications for existing

projects funded by the Corporation.

18. Consideration of matters relating to the stated purpose of

the Corporation to provide safe and sanitary housing that is

affordable for the residents of Florida.

19. Consideration of funding additional reserves for the

Guarantee Fund.

20. Consideration of audit issues.

21. Evaluation of professional and consultant performance.

22. Such other matters as may be included on the Agenda for

the October 26, 2018, Board Meeting.

A copy of the agenda may be obtained by contacting:

Approximately two days prior to the meeting by contacting

Sheila Freaney, Board Liaison, Florida Housing Finance

Corporation, 227 North Bronough Street, Suite 5000,

Tallahassee, Florida 32301-1329, phone number: (850)488-

4197 or by visiting the Corporation’s website at

www.floridahousing.org.

Pursuant to the provisions of the Americans with Disabilities

Act, any person requiring special accommodations to

participate in this workshop/meeting is asked to advise the

agency at least 5 days before the workshop/meeting by

contacting: Sheila Freaney at the Florida Housing Finance

Corporation at (850)488-4197.

If any person decides to appeal any decision made by the

Corporation with respect to any matter considered at this

meeting, he or she will need a record of the proceedings, and

for such purpose, he or she may need to ensure that a verbatim

record of the proceedings be made, which record includes the

testimony and evidence upon which the appeal is to be based.

If you are hearing or speech impaired, please contact the agency

using the Florida Relay Service, 1(800)955-8771 (TDD) or

1(800)955-8770 (Voice).

FLORIDA HOUSING FINANCE CORPORATION

The Florida Housing Finance Corporation announces a hearing

to which all persons are invited.

DATE AND TIME: October 9, 2018, 10:00 a.m. (Tallahassee

local time)

PLACE: The offices of Florida Housing Finance Corporation,

227 North Bronough Street, Suite 5000, Tallahassee Florida

32301

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4366

GENERAL SUBJECT MATTER TO BE CONSIDERED: To

conduct a TEFRA hearing concerning the potential future

issuance of a tax-exempt bonds by Florida Housing to provide

additional financing for the acquisition, construction or

rehabilitation of the following multifamily residential rental

development in the aggregate face amount, not to exceed the

amount listed below:

Ambar Key Homes, a 155-unit multifamily residential rental

development located at 380 NE 4th Ave, Florida City, Miami-

Dade County, FL. The owner and operator of the development

is Ambar Key Homes, Ltd., 13611 S. Dixie Hwy., Ste. 374,

Miami, FL 33176 or such successor in interest in which Ambar

Key Homes, Ltd., or an affiliate thereof, is a managing member,

general partner and/or controlling stockholder. The prospective

manager of the proposed development is Royal American

Management, Inc., 1002 West 23rd Street, Suite 400, Panama

City, FL 32405. The tax-exempt bond amount is not to exceed

$18,150,000.

All interested parties may present oral comments at the public

TEFRA hearing or submit written comments regarding the

potential bond issuance for the development being financed.

Written comments should be received by Florida Housing by

5:00 p.m. (Tallahassee local time), September 30, 2018, and

should be addressed to the attention of Tim Kennedy, Assistant

Director of Multifamily Programs. Any persons desiring to

present oral comments should appear at the hearing.

If requested in writing, a fact-finding hearing will be held in the

county where the property is located. When possible, the local

hearing will be held before the formal TEFRA hearing and

comments received at the local hearing will be placed on record

at the TEFRA hearing.

Any person requiring a special accommodation at this meeting

because of a disability or physical impairment should contact

Tim Kennedy, Assistant Director of Multifamily Programs,

Florida Housing Finance Corporation at (850)488-4197 at least

five calendar days prior to the meeting. If you are hearing

impaired, please contact Florida Housing using the Dual Party

Relay System that can be reached at 1(800)955-8770 (Voice)

and 1(800)955-8771 (TDD).

Any person who decides to appeal any decision made by

Florida Housing with respect to any matter considered at this

hearing, will need a record of the proceedings, and for such

purpose may need to ensure that a verbatim record of the

proceedings be made, which will include the testimony and

evidence upon which the appeal is based.

A copy of the agenda may be obtained by contacting: For more

information, you may contact: Tim Kennedy, Assistant Director

of Multifamily Programs.

FLORIDA HOUSING FINANCE CORPORATION

The Florida Housing Finance Corporation announces a hearing

to which all persons are invited.

DATE AND TIME: October 9, 2018, 10:30 a.m. (Tallahassee

local time)

PLACE: The offices of Florida Housing Finance Corporation,

227 North Bronough Street, Suite 5000, Tallahassee Florida

32301

GENERAL SUBJECT MATTER TO BE CONSIDERED: To

conduct a TEFRA hearing concerning the potential future

issuance of a tax-exempt bonds by Florida Housing to provide

additional financing for the acquisition, construction or

rehabilitation of the following multifamily residential rental

development in the aggregate face amount, not to exceed the

amount listed below:

Ambar Key, a 94-unit multifamily residential rental

development located on NE 3rd Ave, SW of the intersection of

NE 3rd Ave. and NE 4th St., NE 3rd Ave, SE of the intersection

of NE 3rd Ave. and NE 4th St., NE 3rd Ave, SE of the

intersection of NE 3rd Ave. and NE 2nd Terr., and NE 3rd Ave,

SE of the intersection of NE 3rd Ave. and NE 2nd St, all in

Florida City, Miami-Dade County, FL. The owner and operator

of the development is Ambar Key, Ltd., 13611 S. Dixie Hwy.,

Ste. 374, Miami, FL 33176 or such successor in interest in

which Ambar Key, Ltd., or an affiliate thereof, is a managing

member, general partner and/or controlling stockholder. The

prospective manager of the proposed development is Royal

American Management, Inc., 1002 West 23rd Street, Suite 400,

Panama City, FL 32405. The tax-exempt bond amount is not to

exceed $12,100,000.

All interested parties may present oral comments at the public

TEFRA hearing or submit written comments regarding the

potential bond issuance for the development being financed.

Written comments should be received by Florida Housing by

5:00 p.m. (Tallahassee local time), September 30, 2018, and

should be addressed to the attention of Tim Kennedy, Assistant

Director of Multifamily Programs. Any persons desiring to

present oral comments should appear at the hearing.

If requested in writing, a fact-finding hearing will be held in the

county where the property is located. When possible, the local

hearing will be held before the formal TEFRA hearing and

comments received at the local hearing will be placed on record

at the TEFRA hearing.

Any person requiring a special accommodation at this meeting

because of a disability or physical impairment should contact

Tim Kennedy, Assistant Director of Multifamily Programs,

Florida Housing Finance Corporation at (850)488-4197 at least

five calendar days prior to the meeting. If you are hearing

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4367

impaired, please contact Florida Housing using the Dual Party

Relay System that can be reached at 1(800)955-8770 (Voice)

and 1(800)955-8771 (TDD).

Any person who decides to appeal any decision made by

Florida Housing with respect to any matter considered at this

hearing, will need a record of the proceedings, and for such

purpose may need to ensure that a verbatim record of the

proceedings be made, which will include the testimony and

evidence upon which the appeal is based.

A copy of the agenda may be obtained by contacting: For more

information, you may contact: Tim Kennedy, Assistant Director

of Multifamily Programs.

MOFFITT CANCER CENTER & RESEARCH INSTITUTE

The Florida Cancer Control & Research Advisory Council

(CCRAB) announces a telephone conference call to which all

persons are invited.

DATE AND TIME: Thursday, September 27, 2018, 1:00 p.m.,

ET

PLACE: 1(800)206-6032; Passcode: 7451520#

GENERAL SUBJECT MATTER TO BE CONSIDERED:

CCRAB Executive Team call to discuss CCRAB business.

A copy of the agenda may be obtained by contacting:

[email protected].

For more information, you may contact:

[email protected].

Section VII

Notice of Petitions and Dispositions

Regarding Declaratory Statements

NONE

Section VIII

Notice of Petitions and Dispositions

Regarding the Validity of Rules

Notice of Petition for Administrative Determination has been

filed with the Division of Administrative Hearings on the

following rules:

NONE

Notice of Disposition of Petition for Administrative

Determination has been filed with the Division of

Administrative Hearings on the following rules:

NONE

Section IX

Notice of Petitions and Dispositions

Regarding Non-rule Policy Challenges

NONE

Section X

Announcements and Objection Reports of

the Joint Administrative Procedures

Committee

NONE

Section XI

Notices Regarding Bids, Proposals and

Purchasing

DEPARTMENT OF AGRICULTURE AND CONSUMER

SERVICES

Division of Administration

PAVING AT WITHLACOOCHEE STATE FOREST,

CROOM MOTORCYCLE AREA

As a contractor, you are invited to submit a bid to the Florida

Department of Agriculture and Consumer Services, Florida

Forest Service, hereinafter referred to as owner, for a paving

project at the Withlacoochee State Forest, Croom Motorcycle

Area, located at 6420 LaRose Road, Brooksville, Florida. The

project budget is estimated to be approximately $495,000.

The contractor shall provide all materials, labor and equipment

necessary to successfully complete the project in accordance

with the terms and conditions of the Invitation to Bid.

PROJECT NAME AND LOCATION: Paving at

Withlacoochee State Forest, Croom Motorcycle Area, located

at 6420 LaRose Road, Brooksville, Florida.

SOLICITATION DOCUMENT: The entire solicitation

document, which includes specifications, may be viewed and

downloaded from the Vendor Bid System

http://www.myflorida.com/apps/vbs/vbs_www.search_r2.crite

ria_form, Bid Number ITB/ FFS-18/19-28, or by calling the

purchasing office at (850)617-7181.

MANDATORY PRE-BID CONFERENCE/SITE VISIT: Each

bidder must, before submitting a bid, attend the mandatory pre-

bid conference/site visit. The pre-bid conference/site visit will

be held at 2:00 p.m., EST, on October 8, 2018, at the

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4368

Withlacoochee State Forest, Croom Motorcycle Area, located

at 6420 LaRose Road, Brooksville, Florida. During the pre-bid

conference, a site visit will be held for prospective bidders. It

is the bidders' responsibility to consider any and all site

conditions or requirements for the project. Specifications will

be available at the mandatory pre-bid conference/site visit.

PUBLIC ENTITY CRIME INFORMATION STATEMENT:

A person or affiliate, who has been placed on the convicted

vendor list following a conviction for a public entity crime; may

not submit a bid on a contract to provide any goods or services

to a public entity; may not submit a bid on a contract with a

public entity for the construction or repair of a public building

or public work; may not submit bids on leases of real property

to a public entity; may not be awarded or perform work as a

contractor, supplier, subcontractor or consultant under a

contract with any public entity and may not transact business

with any public entity in excess of the threshold amount

provided in Section 287.017, Florida Statutes, for category two,

for a period of 36 months from the date of being placed on the

convicted vendor list.

DISCRIMINATION, DENIAL OR REVOCATION FOR THE

RIGHT TO TRANSACT BUSINESS WITH PUBLIC

ENTITIES: An entity or affiliate, who has been placed on the

discriminatory vendor list, may not submit a bid on a contract

to provide goods or services to a public entity; may not submit

a bid on a contract with a public entity for the construction or

repair of a public building or public work; may not submit bids

on leases of real property to a public entity; may not award or

perform work as a contractor, supplier, subcontractor or

consultant under contract with any public entity and may not

transact any business with any public entity.

PERFORMANCE BOND AND LABOR AND MATERIAL

PAYMENT BOND: Each bid shall be accompanied by a

performance bond in the amount of one-hundred percent

(100%) of the base bid price.

BID BOND: Each bid shall be accompanied by a bid bond

guarantee payable to the Department in the amount of five

percent (5%) of the base bid price.

Sealed bids will be received, publicly opened and read aloud

on:

DATE AND TIME: October 26, 2018, 2:00 p.m.

PLACE: Florida Department of Agriculture and Consumer

Services, 407 S. Calhoun Street, SB-8, Mayo Building,

Tallahassee, Florida 32399-0800, (850)617-7181.

CONTRACT AWARD: The official Notice of Award

Recommendation will be by electronic posting at

http://fcn.state.fl.us/owa_vbs/owa/vbs_www.main_menu.

Failure to file a protest within the time prescribed in subsection

120.57(3), Florida Statutes, shall constitute a waiver of

proceedings under Chapter 120, Florida Statutes. If no protest

is filed, the contract will be awarded to the qualified, responsive

low bidder in accordance with Chapter 60D-5, F.A.C. by the

owner.

DEPARTMENT OF EDUCATION

University of South Florida

USF 581 - USF Football Center CM

NOTICE TO CONSTRUCTION MANAGERS

The University of South Florida (USF) announces that

Construction Management at Risk services will be required for

the project listed below:

PROJECT NUMBER: USF 581

PROJECT AND LOCATION: USF Football Center,

University of South Florida, Tampa Campus, Tampa, Florida.

PROJECT DESCRIPTION: The USF Football Center project

is a new 165,000 GSF, 2 story facility, consisting of two

specialized, major elements: new Football Operations Building

(67,000 GSF) and new Indoor Practice Facility (99,000 GSF).

The Football Operations Building will house the team,

coaching, training and operational functions of the USF

Football Program, and the Indoor Practice facility will provide

an enclosed and environmentally-controlled synthetic turf

practice field for the USF Football and other sports programs.

The project construction budget (pending) is: $13,000,000 for

the Indoor Practice Facility and $19,500,000 for the Football

Operations Building for a total construction project budget of

$32,500,000. The project delivery method is Construction

Management at Risk and includes site improvements,

underground utilities, fees, surveys & tests, total building

commissioning, furnishings & equipment, and building

construction.

The contract for construction management services will consist

of two phases, pre-construction and construction. Phase one

pre-construction services, for which the Construction Manager

will be paid a fixed fee, will begin with the Design

Phase. Phase one services include value engineering,

constructability analyses, job site management coordination,

create construction schedule, development of a cost model,

estimating, and the development of a Guaranteed Maximum

Price (GMP) at 50% Construction Documents phase of each

facility (IPF and FOB). If the GMP is accepted, phase two, the

construction phase, will be implemented. In phase two of the

contract, the Construction Manager becomes the single point of

responsibility for performance of the construction of the project

and shall publicly bid trade contracts, ensuring the inclusion of

Certified Business Enterprise (CBE) including certified

Minority (MBE), Women (WBE), and Veteran (VBE) Business

Enterprises. Early bid packages for fast track and/or multi-

phase development may be required to meet project

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4369

goals. Failure to negotiate an acceptable fixed fee for phase one

of the contract, or to arrive at an acceptable GMP within the

time provided in the agreement may result in the termination of

the construction manager’s contract. The respondent must be

capable of bonding at 100% of the value of the contract with a

surety licensed to do business in the State of Florida with a Best

Rating A, Class IX. Project development including

construction management services is contingent upon

availability of funds. If additional funding is realized, the USF

has the option to incorporate additional scope/funding under

this contract. Any new construction projects shall be USGBC

LEED certified, to a minimum certification level of Silver, as

required by the Owner, and shall be included as part of basic

services and will not be considered as an additional service.

PROJECT SELECTION CRITERIA: Evaluation of applicant

qualifications for finalist interviews will be made on the basis

of experience; ability to perform; bonding capacity;

recordkeeping/administrative ability; critical path scheduling

expertise; cost estimating experience; cost control ability;

quality control capability; and qualification of the firm's

personnel, staff and consultants, and locations. Finalists will be

provided with a copy of the building program and the latest

documentation prepared by the project architect/engineer, a

description of the final interview requirements and a copy of the

standard USF construction management agreement. The

construction manager shall have no ownership, entrepreneurial,

or financial affiliation with the selected Architect/Engineer

involved with this project.

As part of the USF Strategic Plan, USF made a commitment to

foster a diverse community distinguished by a shared purpose,

collaboration, open and timely communication, mutual respect,

trust, and inclusiveness. The USF is an equal opportunity

institution, and, as such, strongly encourages the lawful use of

Certified Business Enterprises (CBE) in the provision of design

and construction-related services by providing a fair and equal

opportunity to compete for, or for participation in, design and/or

construction-related services. CBE participation information

shall be provided by the firm in response to a periodic request

from the USF Supplier Diversity Program office.

As required by Section 287.133, Florida Statutes, a construction

management firm may not submit a proposal for this project if

it is on the convicted vendor list for a public entity crime

committed within the past 36 months. The selected

construction management firm must warrant that it will neither

utilize the services of, nor contract with, any supplier,

subcontractor, or consultant in excess of $25,000.00 in

connection with this project for a period of 36 months from the

date of placement on the convicted vendor list.

In accordance with Section 287.055, Florida Statutes, a fair,

competitive and reasonable compensation shall be evaluated

based upon the following information: (1) Compensation on

similar projects; (2) other compensation reference data; and (3)

after approval of the ranking, proposals requested from the

shortlisted firms based upon a scope of services document to be

provided at the time of negotiations.

INSTRUCTIONS:

Firms desiring to provide professional services shall submit one

(1) original submittal and seven (7) spiral bound copies

consisting of the information as required in the submittal

requirements of the Construction Manager Request for

Qualification (RFQ) including a letter of interest, a completed

USF Construction Manager Qualifications Supplement

(CMQS) form, and any required or additional information

within the proposal limits. Applications on any other form will

not be considered. Applications which do not comply with the

above instructions may be disqualified. Submittals are part of

the public record. Application materials will not be

returned. All applicants must be licensed to practice as a

General Contractor in the State of Florida at the time of

application. If the applicant is a corporation, or a joint venture,

it must be chartered by the Florida Department of State to

operate in Florida.

Request for Meetings: No verbal communication shall take

place between the applicants and the employees of the USF

except as provided at the Pre-Submittal Meeting, the Pre-

Interview Meeting and in the CMQS and Construction Manager

Request for Qualifications (RFQ) (which includes project

information and selection criteria). Requests for meetings by

individual firms will not be granted.

Request for Information: Requests for any project information,

including the CMQS and RFQ must be submitted in writing or

email to: Terry Mead, University of South Florida, Facilities

Management - Design & Construction, 4202 East Fowler

Avenue / OPM 100, Tampa, FL 33620-7550, [email protected],

1(813)974-0843, or Fax: 1(813)974-3542.

Pre-Submittal Meeting: All interested firms are invited and

encouraged to attend a Pre-Submittal Meeting to be held at 9:00

a.m., October 9, 2018, at the: University of South Florida,

Tampa Campus, Patel Center for Global Solutions, Auditorium,

11710 Maple Drive, Tampa, FL 33620, to review the scope and

requirements of this project. (Directions and parking

information can be obtained at the Campus Information Center

at the Fowler entrance, or view map at website:

www.usf.edu/administrative-

services/parking/maps/index.aspx).

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4370

Submission: Submittals are to be received in the University of

South Florida, Facilities Management- Design & Construction

Office, 4202 East Fowler Avenue / OPM 100, Tampa, FL

33620-7550 by 2:00 p.m., October 23, 2018 Facsimile (FAX)

or electronic submittals are not acceptable and will not be

considered. Submittals that do not comply with the above

instructions may be disqualified. The Selection Committee

may reject all proposals and stop the selection process at any

time.

FLORIDA A&M UNIVERSITY FACILITIES PLANNING,

CONSTRUCTION AND SAFETY

DEPARTMENT OF EDUCATION Florida Agricultural and

Mechanical University

NOTICE TO PROFESSIONAL CONSULTANTS

Florida A&M University (FAMU) announces that Professional

Services in the discipline of Architecture will be required for

the following: FAMU New –Student Services Facility: The

selected firm will provide design, construction documents and

administration for the referenced project. This project will

consist of design not to exceed 12,000 GSF of space to include

a C-store, Business Center, Pizza Stand, Bravo area, Soup and

Salad station, Hot Entrée, Dessert and Cereal Stations, Grille

and seating for +300 seats. Blanket professional liability

insurance will be required for this project in the amount of

$1,000,000.00 and will be provided as a part of Basic Services.

A copy of the Project FACT Sheet can be obtained by

contacting Craig Talton, Director, (850)599-3197.

INSTRUCTIONS: Firms desiring to apply for consideration

shall submit a letter of application.

The letter of application should have attached:

1. A completed “Professional Qualifications Supplement”

(PQS) ; form is to be obtained from the FAMU Facilities

Planning and Construction Office. Applications on any other

form will not be considered.

2. A copy of the applicant’s current Professional Registration

Certificate from the appropriate governing board. An applicant

must be properly registered at the time of application to practice

its profession in the State of Florida. If the applicant is a

corporation, it must be chartered by the Florida Department of

State to operate in Florida.

3. Submit nine (9) three ring, comb or spiral (no hard, solid or

tack) bound copies of the requested data in the order listed

above. Applications which do not comply with the above

instructions may be disqualified. Application materials will not

be returned. The plans and specifications for State University

System projects are subject to reuse in accordance with the

provisions of Section 287.055, Florida Statutes. FAMU is an

equal opportunity institution, and, as such, strongly encourages

the lawful use of certified Minority and Women-owned

Business Enterprises (“MBEs”) in the provision of design and

construction-related services by providing a fair and equal

opportunity to compete for, or for participation in, design and/or

construction-related services. As required by Section 287.133,

Florida Statutes, a consultant may not submit a proposal for this

project if it is on the convicted vendor list for a public entity

crime committed within the past 36 months. The selected

consultant must warrant that it will neither utilize the services

of, nor contract with, any supplier, subcontractor, or consultant

in excess of $25,000 in connection with this project for a period

of 36 months from the date of their being placed on the

convicted vendor list.

4. Professional Qualifications Supplement (PQS) forms,

descriptive project information, and selection criteria may be

obtained by contacting: Craig Talton, Director, Office of

Facilities Planning and Construction, Florida A&M University,

Plant Operations Facility, Building A, Suite 100, 2400 Wahnish

Way, Tallahassee, Florida 32307, (850)599-3197 Fax:

(850)561-2289, Email: [email protected].

Submittals must be received between 8:00 a.m. and 5:00 p.m.

local time, Tuesday, October 23, 2018. Submittals will not be

accepted after the times and date stated above. Facsimile (FAX)

submittals are not acceptable and will not be considered.

Submittal Address:

The Nine (9) hard copies and the electronic copy (on a CD or

USB) of the SOQ shall be submitted to: Florida A&M

University, Office of Procurement Services, 2380 Wahnish

Way, Suite 214, Tallahassee, FL 32307

Attn: Craig Talton, Director of Facilities Planning and

Construction

Section XII

Miscellaneous

DEPARTMENT OF STATE

Index of Administrative Rules Filed with the Secretary of State

Pursuant to Section 120.55(1)(b)6. – 7., F.S., the below list of

rules were filed in the Office of the Secretary of State between

3:00 p.m., Friday, September 14, 2018 and 3:00 p.m., Thursday,

September 20, 2018.

Rule No. File Date Effective

Date

1T-1.042 9/20/2018 10/10/2018

33-208.101 9/19/2018 10/9/2018

33-602.101 9/19/2018 10/9/2018

42MMM-1.002 9/19/2018 10/9/2018

62B-33.0085 9/14/2018 10/4/2018

Florida Administrative Register Volume 44, Number 185, September 21, 2018

4371

62B-33.014 9/14/2018 10/4/2018

62B-33.0155 9/14/2018 10/4/2018

62B-33.024 9/14/2018 10/4/2018

62B-34.030 9/14/2018 10/4/2018

62B-34.040 9/14/2018 10/4/2018

62B-34.070 9/14/2018 10/4/2018

62B-34.085 9/14/2018 10/4/2018

64B5-2.014 9/14/2018 10/4/2018

64B5-2.0142 9/14/2018 10/4/2018

64B5-2.0146 9/14/2018 10/4/2018

64B5-7.003 9/14/2018 10/4/2018

64B5-7.0035 9/14/2018 10/4/2018

64B5-7.005 9/14/2018 10/4/2018

64B5-7.007 9/14/2018 10/4/2018

64B16-28.750 9/20/2018 10/10/2018

64E-3.002 9/14/2018 10/4/2018

64E-3.0034 9/14/2018 10/4/2018

LIST OF RULES AWAITING LEGISLATIVE

APPROVAL SECTIONS 120.541(3), 373.139(7)

AND/OR 373.1391(6), FLORIDA STATUTES

Rule No. File Date Effective

Date

60FF1-5.009 7/21/2016 **/**/****

64B8-10.003 12/9/2015 **/**/****

DEPARTMENT OF FINANCIAL SERVICES

FSC - Financial Institution Regulation

Office of Financial Regulation

NOTICE OF FILINGS

Financial Services Commission

Office of Financial Regulation

September 21, 2018

Notice is hereby given that the Office of Financial Regulation,

Division of Financial Institutions, has received the following

application. Comments may be submitted to the Division

Director, 200 East Gaines Street, Tallahassee, Florida 32399-

0371, for inclusion in the official record without requesting a

hearing. However, pursuant to provisions specified in Chapter

69U-105, Florida Administrative Code, any person may request

a public hearing by filing a petition with the Agency Clerk as

follows:

By Mail or Facsimile OR By Hand Delivery

Agency Clerk Agency Clerk

Office of Financial Regulation Office of Financial

Regulation

P.O. Box 8050 General Counsel’s Office

Tallahassee, Florida 32314-8050 The Fletcher

Building, Suite 118

Phone: (850)410-9889 101 East Gaines Street

Fax: (850)410-9663 Tallahassee, Florida

32399-0379

Phone: (850)410-9889

In accordance with the Americans with Disabilities Act,

persons with disabilities needing a special accommodation to

participate in this proceeding should contact the Agency Clerk

no later than seven (7) days prior to the filing deadline or

proceeding, at the Office of Financial Regulation, The Fletcher

Building, Suite 118, 101 East Gaines Street, Tallahassee,

Florida 32399-0379, Phone: (850)410-9889, or by Email:

[email protected].

The Petition must be received by the Clerk within twenty-one

(21) days of publication of this notice (by 5:00 p.m., November

11, 2018):

APPLICATION FOR A QUALIFIED LIMITED SERVICE

AFFILIATE

Applicant and Location: Harneys Fiduciary (Miami) Inc., 1221,

Brickell Avenue, 9th Floor, Miami, Florida, 33131

Received: August 22, 2018

Distribution: (Publication Not Required)

Federal Deposit Insurance Corporation, Atlanta, GA

Federal Reserve Bank of Atlanta, Atlanta, GA

Comptroller of the Currency, Atlanta, GA

Raquel A. Rodriguez

Section XIII

Index to Rules Filed During Preceding

Week

NOTE: The above section will be published on Tuesday

beginning October 2, 2012, unless Monday is a holiday, then it

will be published on Wednesday of that week.